AORT Artivion Inc: Debts to Book Capitalization

Corporate company logo of CryoLife (AORT)

The price visualization for Artivion, Inc. (AORT) on GURU.Markets illustrates the asset's dynamics, where the current indicator stands at 0.86. Artivion, Inc. specializes in the development of heart valves and aortic surgery systems, leveraging the success of On-X and the approval of new stent grafts. The company's environmental focus centers on bioethics and energy efficiency during implant production. Its strategic course is aimed at the global promotion of tissue processing methods and the maintenance of high profitability.

Artivion Corp - AORT Debts to Net Assets (period 07/04/2022 - 10/30/2026)
Original product of CryoLife

Artivion, Inc. (AORT) investments in the robotization of bioprosthesis production require significant capital, meaning the debt-to-book capitalization ratio trend allows for an assessment of the efficiency of borrowed funds utilization. This indicator measures the degree of financial leverage by comparing total accounts payable to equity, helping investors determine the balance between default risk and the potential for increased return on assets.

Direct competitors

Debts to Book Capitalization BSX (Boston Scientific)|edwards.com (EW) - Debts to Book Value|ResMed - Debts to Book Capitalization|Insulet Corp (PODD) - Debt to Book Value|ZBH: Debts to Book Capitalization|COO - Debts to Net Assets|ALGN (Align Technology, Inc.) - Debts to Book Capitalization|Debts to Book Capitalization globusmedical.com|Debt to Book Capitalization Ratio TransMedics Organ Care System (TMDX)|Debt to Book Capitalization Ratio ATEC (Alphatec Holdings)|Debts to Book Capitalization ENOV (DJO Global)|Debts to Net Assets Integra LifeSciences Inc. (IART)|ESTA: Debt to Book Value|Debts to Book Capitalization Ratio BBNX|IRMD: Debts to Book Capitalization|Debts to Book Value Embecta Corp (EMBC)|TNDM (Tandem Diabetes) - Debts to Book Capitalization|Debt to Book Value Ratio AXGN (Axogen Surgical)|Debt to Book Value SIBN (SI-BONE, Inc.)|OFIX (orthofix.com) - Debt to Net Assets Ratio|Debt to Book Capitalization Ratio Bioventus BVS|KIDS - Debt to Book Value|Treace Medical - Debts to Book Capitalization|Debts to Book Value Strata Medical|CARL: Debts to Book Capitalization|Debt to Book Value Ratio RXST|CLPT (ClearPoint Neuro Inc.) - Debts to Book Capitalization|Stereotaxis Inc (STXS) - Debts to Net Assets|Debts to Book Capitalization STIM|Debt to Book Value Sight Sciences Inc SGHT|Debts to Book Capitalization OBIO (Orchestra BioMed, Inc.)|Debts to Book Capitalization Anika Therapeutics Inc. ANIK|NSPR - Debt to Book Capitalization Ratio|ZJYL: Debt to Book Capitalization Ratio|VANI (vivani.com) - Debt to Book Value|Xtant Medical - Debt to Net Assets Ratio|NMTC (NeuroOne Medical Technologies) - Debts to Book Capitalization|Debts to Book Value Modular Med MODD|Debt to Book Capitalization Ratio Myomo (MYO)|Envoy Medical Inc. (COCH) - Debt to Net Assets|Vivos Therapeutics, Inc - Debt to Book Value|Debts to Book Capitalization enVVeno Corp NVNO|SINTX Technologies - Debts to Book Capitalization|Debts to Net Assets tenonmed.com TNON|Lifeward (LFWD) - Debt to Book Capitalization Ratio|Debts to Book Capitalization Ratio AMIX (Autonomix Medical)|Debt to Book Capitalization Ratio INVO Bioscience, Inc.|Debt to Book Value Bone Biologics Inc (BBLG)|Debts to Book Capitalization AXNX|BIOL - Debts to Book Value|Debt to Book Capitalization Ratio Dynatronics DYNT|FNA: Debt to Book Value Ratio|INVO: Debt to Book Value